Dermatology · Columbia, SC
NPI
1285611525
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1709 Barnwell St
Columbia, SC, 29201
Phone (803) 254-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
31,557 services
Medicare patients, 2024
1,841
Average age 75
Drug cost, 2024
$725K
2,267 prescriptions
Company payments, 2025
$815
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dina V Hunter was code 17003 (destruction skin lesion), 9,006 times for 650 patients. In total Dina V Hunter billed 31,557 services in 102 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 9,006 | 650 | $4.53 | $41K |
| 88305 Surgical Pathology Examination | Office | 5,932 | 1,287 | $26.99 | $160K |
| 99213 Office E&M - Established | Office | 1,907 | 1,144 | $61.57 | $117K |
| 17004 Destruction Skin Lesion | Office | 1,747 | 1,199 | $117.12 | $205K |
| 11312 Removal or Shaving of Skin Growth | Office | 1,410 | 744 | $100.05 | $141K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 1,182 | 64 | $135.74 | $160K |
| 77280 Radiation Treatment Planning | Office | 1,089 | 62 | $201.05 | $219K |
| 77401 Conventional Radiation Treatment | Office | 1,076 | 61 | $31.38 | $34K |
| 17000 Destruction Skin Lesion | Office | 767 | 654 | $32.32 | $25K |
| 11302 Removal or Shaving of Skin Growth | Office | 754 | 445 | $67.01 | $51K |
| 11307 Removal or Shaving of Skin Growth | Office | 646 | 390 | $67.25 | $43K |
| 11311 Removal or Shaving of Skin Growth | Office | 567 | 426 | $59.84 | $34K |
| 13132 Wound Repair - All Levels | Office | 486 | 365 | $357.16 | $174K |
| 11643 Skin Lesion Excision | Office | 445 | 298 | $114.15 | $51K |
| 11102 Skin Biopsy | Office | 429 | 391 | $46.67 | $20K |
By year: 2022 $1.4M for 23,867 services; 2023 $1.6M for 29,845 services; 2024 $1.9M for 31,557 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 5,932 | 1,287 | $26.99 | $160K |
| 88304 Surgical Pathology Examination | 35 | 34 | $23.70 | $830 |
Medicare prescription drug claims, 2024
In 2024, the drug Dina V Hunter prescribed most often to Medicare patients was Triamcinolone Acetonide, with 298 prescriptions and refills. In total Dina V Hunter wrote 2,267 Medicare prescriptions that cost $725K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 298 | 321 | 193 | $5,129 |
| Clobetasol Propionate Generic | 294 | 300 | 200 | $10K |
| Fluocinolone Acetonide Generic | 261 | 272 | 177 | $9,613 |
| Fluocinonide Generic | 164 | 169 | 119 | $6,996 |
| Doxycycline Hyclate Generic | 143 | 163 | 95 | $2,672 |
| Ciclopirox Ciclopirox Olamine | 132 | 137 | 88 | $2,137 |
| Methotrexate Methotrexate Sodium | 118 | 169 | 22 | $2,504 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 106 | 110 | 68 | $5,096 |
| Finasteride Generic | 67 | 185 | 23 | $1,524 |
| Metronidazole Generic | 55 | 67 | 37 | $4,023 |
| Valacyclovir Valacyclovir Hcl | 52 | 85 | 26 | $1,424 |
| Dutasteride Generic | 50 | 150 | 25 | $1,534 |
| Mupirocin Generic | 38 | 38 | 28 | $247 |
| Hydrocortisone Valerate Generic | 33 | 33 | 26 | $871 |
| Hydroxychloroquine Sulfate Generic | 25 | 35 | Under 11 | $487 |
Brand drugs: 198 claims; generic drugs: 2,069 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dina V Hunter $815 ($815 in general payments such as food, travel and fees) from 6 companies. The largest payer was Genzyme Corporation with $415.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.